JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 17 January 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01585-06v1
81/7/3437    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tami, C.
Right arrow Articles by Kaplan, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tami, C.
Right arrow Articles by Kaplan, G. G.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.01585-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

IgA is a natural ligand of the Hepatitis A virus cellular receptor 1, and their association enhances virus-receptor interactions

Cecilia Tami, Erica Silberstein, Mohanraj Manangeeswaran, Gordon J. Freeman, Sarah E. Umetsu, Rosemarie H. DeKruyff, Dale T. Umetsu, and Gerardo G. Kaplan*

Laboratory of Hepatitis and Related Emerging Agents, CBER, Food and Drug Administration, Bethesda, MD 20892, US; Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115, US; Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, US; and Division of Immunology, Karp Laboratories, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, US

* To whom correspondence should be addressed. Email: GK{at}helix.nih.gov.


   Abstract

The Hepatitis A virus cellular receptor I (HAVCR1/TIM1), a member of the T cell immunoglobulin mucin (TIM) family, is an important atopy susceptibility gene in humans. The exact natural function of HAVCR1/TIM1 and the inverse association between HAV infection and prevention of atopy are not well understood. To identify natural ligands of human HAVCR1/TIM1, we used an expression cloning strategy based on the binding of dog cells transfected with a human lymph node cDNA library to an HAVCR1/TIM1 Fc fusion protein. The transfected cells that bound to the human HAVCR1/TIM1 Fc contained cDNA of human immunoglobulin alpha-1 heavy (Ig{alpha}1) and lambda light (Ig{lambda}) chain, and secreted human IgA1{lambda} antibody that bound to the cell surface. Cotransfection of the isolated Ig{alpha}1 and Ig{lambda} cDNAs to naïve dog cells resulted in the secretion of IgA1{lambda} that bound to HAVCR1/TIM1 Fc but not to a poliovirus receptor Fc fusion protein in a capture ELISA. The interaction of HAVCR1/TIM1with IgA was inhibited with monoclonal antibodies (mAb) against Ig{alpha}1 and Ig{lambda}, excess IgA1{lambda}, or anti-HAVCR1/TIM1 mAb. IgA did not inhibit HAV infection of African green monkey cells suggesting that the IgA and the virus binding sites are in different epitopes on the HAVCR1/TIM1. IgA enhanced significantly the neutralization of HAV by HAVCR1/TIM1 Fc. Our results indicate that IgA1{lambda} is a specific ligand of HAVCR1/TIM1 and that their association has a synergistic effect in virus-receptor interactions.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.